FHL1-mutated reducing body myopathy.

Area of Science:

• Neurology
• Genetics
• Pathology

Background:

• Reducing body myopathy is a rare neuromuscular disorder.
• Mutations in the four and a half LIM domain 1 (FHL1) gene are implicated in certain myopathies.
• Accurate diagnosis often requires advanced genetic analysis.

Observation:

• A 40-year-old woman presented with progressive muscle weakness and limping gait since childhood.
• Clinical findings included elevated muscle enzymes and MRI abnormalities.
• Muscle biopsy showed severe dystrophic features with characteristic reducing bodies and ubiquitin accumulation.

Findings:

• Whole-exome sequencing identified a missense mutation (p.C150R, c.T448C) in the FHL1 gene (NM_001159704) in exon 4.
• This genetic finding confirmed FHL1-mutated reducing body myopathy.
• The specific ultrastructural and pathological features were documented.

Implications:

• This case highlights the importance of genotype-phenotype correlation for diagnosing rare myopathies.
• Recognizing the unique features of FHL1-related reducing body myopathy can aid in earlier and more accurate diagnosis.
• Further research into FHL1 mutations may reveal more about myofibrillar myopathies.